08/11/2025
🇸🇪 From 25 Years of Stem Cell Research in Sweden… to Clinical Trials in the Bahamas 🇧🇸
Did you know that the stem cells being used in new clinical trials in the Bahamas actually come from over 25 years of research in Sweden?
These mesenchymal stem cells (MSCs) are produced in a GMP – Good Manufacturing Practice – certified laboratory, which means they’re made to the same kind of standards used for medicines:
• Strict quality control at every step
• Careful checking of cell identity, purity and viability
• Continuous monitoring by the Swedish authorities
Once the cells are prepared under these pharmaceutical-grade conditions in Sweden, they’re cryo-shipped in liquid nitrogen all the way to the Bahamas, with GPS temperature tracking to make sure they stay at exactly the right conditions during the journey.
In the Bahamas, the cells are being used in regulated clinical trials looking at:
• Cardiovascular disease (CVD) prevention
• Musculoskeletal degeneration and injuries
The trials have been approved by The Bahamas National Stem Cell Ethics Committee and the Ministry of Health (October 2023). In Nassau, the cells are:
• Reconstituted in a dedicated laboratory under strict protocols
• Checked again for cell viability and cell counts
• Injected within a 2-hour window, to keep them as fresh and effective as possible for the study
It’s important to say that these are clinical trials, not routine treatments – the aim is to carefully test safety and potential benefits under controlled conditions.
But it’s exciting to see long-term Swedish stem cell science and high-level manufacturing standards now being applied in real-world trials that could shape future care for heart and musculoskeletal health.
As always, this is information, not personal medical advice – but I thought some of you would be interested in what’s happening behind the scenes in regenerative medicine. 💙
https://www.cellcolabsclinical.com/cellcolabs-clinical-webinar/